Product Information

OLOPATADINE 665 MCG NASAL SPRY is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $0.8678 per GM under NDC 65162089023. Its NADAC has been published 272 times since Jun 9, 2021.

FDA first approved this application on Jan 28, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OLOPATADINE 665 MCG NASAL SPRY

Olopatadine Hydrochloride
$0.8678per GM

Strength

665 ug/1

NDC

65162089023

Classification

Generic

Dosage Form

SPRAY, METERED

Route

NASAL

Effective Date

8/19/2026

Active Ingredients

OLOPATADINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA210901

FDA Approved

1/28/2020

TE Code

AB

On Market Since

2/3/2020

Pharmacological Classes

Decreased Histamine Release
Histamine H1 Receptor Antagonists
Histamine-1 Receptor Antagonist
Histamine-1 Receptor Inhibitor
Mast Cell Stabilizer

Price Statistics

The NADAC for OLOPATADINE 665 MCG NASAL SPRY has been published 272 times since Jun 9, 2021, and over the history we have for it it has declined 52.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.8678 per GM
All-time high$1.8132 (Jun 16, 2021)
All-time low$0.7522 (May 22, 2024)
52-week high$1.0022
52-week low$0.8568
Median price$1.0079
Average price$1.0767
Largest weekly change+34.0% (Jun 19, 2024)
Weeks tracked272
Tracking sinceJun 9, 2021

Price History

1W

+0.8%

1M

+0.8%

3M

-7.6%

6M

+1.3%

1Y

-13.4%

3Y

-13.1%

5Y

-48.2%

All

-52.1%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of OLOPATADINE 665 MCG NASAL SPRY?

The current National Average Drug Acquisition Cost (NADAC) for OLOPATADINE 665 MCG NASAL SPRY, manufactured by Amneal Pharmaceuticals LLC, is $0.8678 per GM (NDC 65162089023), effective Aug 19, 2026.

How has the price of OLOPATADINE 665 MCG NASAL SPRY changed over time?

Over the history we have for it, the NADAC for OLOPATADINE 665 MCG NASAL SPRY has declined 52.1%. It has been tracked across 272 weekly CMS publications since Jun 9, 2021.

What are the highest and lowest recorded NADAC prices for OLOPATADINE 665 MCG NASAL SPRY?

Since Jun 9, 2021, the NADAC for OLOPATADINE 665 MCG NASAL SPRY has ranged from a low of $0.7522 (May 22, 2024) to a high of $1.8132 (Jun 16, 2021), with a median of $1.0079 per GM.

Are there cheaper alternatives to OLOPATADINE 665 MCG NASAL SPRY?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as OLOPATADINE 665 MCG NASAL SPRY in a comparable dosage form, but none are currently priced below it.

Who manufactures OLOPATADINE 665 MCG NASAL SPRY?

OLOPATADINE 665 MCG NASAL SPRY (NDC 65162089023) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.